These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16569842)

  • 1. Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome.
    Park BJ; Arthington-Skaggs BA; Hajjeh RA; Iqbal N; Ciblak MA; Lee-Yang W; Hairston MD; Phelan M; Plikaytis BD; Sofair AN; Harrison LH; Fridkin SK; Warnock DW
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1287-92. PubMed ID: 16569842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro amphotericin B susceptibility of korean bloodstream yeast isolates assessed by the CLSI broth microdilution method, Etest, and Minimum fungicidal concentration test].
    Park JY; Shin JH; Uh Y; Kim EC; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Korean J Lab Med; 2008 Oct; 28(5):346-52. PubMed ID: 18971615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species.
    Cantón E; Pemán J; Viudes A; Quindós G; Gobernado M; Espinel-Ingroff A
    Diagn Microbiol Infect Dis; 2003 Mar; 45(3):203-6. PubMed ID: 12663162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest.
    Peyron F; Favel A; Michel-Nguyen A; Gilly M; Regli P; Bolmström A
    J Clin Microbiol; 2001 Jan; 39(1):339-42. PubMed ID: 11136795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan.
    Chen TC; Chen YH; Tsai JJ; Peng CF; Lu PL; Chang K; Hsieh HC; Chen TP
    J Microbiol Immunol Infect; 2005 Jun; 38(3):200-10. PubMed ID: 15986071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of amphotericin B killing kinetics against seven Candida species.
    Cantón E; Pemán J; Gobernado M; Viudes A; Espinel-Ingroff A
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2477-82. PubMed ID: 15215097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
    Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P
    J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species.
    Pfaller MA; Boyken L; Messer SA; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2004 Nov; 42(11):4977-9. PubMed ID: 15528683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S; Fındık D; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.
    Nguyen MH; Clancy CJ; Yu VL; Yu YC; Morris AJ; Snydman DR; Sutton DA; Rinaldi MG
    J Infect Dis; 1998 Feb; 177(2):425-30. PubMed ID: 9466531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
    Durán MT; Velasco D; Canle D; Moure R; Villanueva R
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
    Rex JH; Pfaller MA; Barry AL; Nelson PW; Webb CD
    Antimicrob Agents Chemother; 1995 Jan; 39(1):40-4. PubMed ID: 7695326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
    Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
    New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia.
    Huang YC; Kao HT; Lin TY; Kuo AJ
    Am J Perinatol; 2001 May; 18(3):141-6. PubMed ID: 11414524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
    Fleck R; Dietz A; Hof H
    J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.